Journal of Gastrointestinal Oncology

Article	Citations
Stage cT3 low rectal cancer: analysis of prognostic factors	48
Construction and validation of a prognostic nomogram for locally recurrent rectal cancer: a population-based study	29
Safety and effectiveness of apatinib in elderly patients with metastatic gastric cancer: a sub-analysis from the large-scale, prospective observational study of apatinib for gastric cancer treatment i	29
Gelatin sponge microparticles for transarterial chemoembolization combined with regorafenib in hepatocellular carcinoma: a single-center retrospective study	26
Transforming hyperthermic intraperitoneal chemotherapy: using computer simulation to improve HIPEC treatments	25
An unusual presentation of solitary ovarian metastasis from colorectal cancer in an elderly woman: a case report	25
The prognostic value of the number of metastatic lymph nodes on the long-term survival of intrahepatic cholangiocarcinoma using the SEER database	25
Prognostic nomogram for T3–T4 primary colorectal cancer patients with perineural invasion after surgery: a Surveillance, Epidemiology, and End Results program database analysis	22
Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study	22
The unique role of cuproptosis in the prognosis and treatment of rectum adenocarcinoma	21
Clinical features and prognostic factors of patients with inoperable hepatocellular carcinoma treated with chemotherapy: a population-based study	20
Lactic acid: a narrative review of a promoter of the liver cancer microenvironment	20
Role of TAP1 in the identification of immune-hot tumor microenvironment and its prognostic significance for immunotherapeutic efficacy in gastric carcinoma	20
Rectal tumor fragmentation as a response pattern following chemoradiation	20
Pattern of distant metastases and predictive nomograms in colorectal mucinous adenocarcinoma: a SEER analysis	18
A narrative review of intraoperative use of indocyanine green fluorescence imaging in gastrointestinal cancer: situation and future directions	17
Impact of new onset diabetes on pancreatic cancer outcomes	16
The combination of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS), interventional hepatoma therapy, targeted therapy, and immunotherapy: a case series of a novel A	16
Prediction of early recurrence in patients with colorectal liver metastases	16
Erratum: Asiaticoside inhibits epithelial-mesenchymal transition and stem cell-like properties of pancreatic cancer PANC-1 cells by blocking the activation of p65 and p38MAPK	16
MMP11 as a prognostic biomarker correlated with immune infiltrates in pancreatic adenocarcinoma	15
Combined hepatocellular carcinoma-cholangiocarcinoma with sarcomatoid features: new insights into a rare and aggressive tumor	15
Path towards personalized care of hepatocellular carcinoma: a nomogram for survival prediction	15
Emerging role of circulating tumor DNA for early detection of recurrence in biliary tract cancers	15
Influence of pre-operative sarcopenia on post-operative hepatic steatosis after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma	15

Treatment paradigms and survival outcomes in esophageal adenocarcinoma with liver metastasis: a retrospective cohort study using the SEER database	15
Anti-PD-1 antibodies plus lenvatinib in patients with unresectable hepatocellular carcinoma who progressed on lenvatinib: a retrospective cohort study of real-world patients	14
A real-world study of oxaliplatin-induced hypersensitivity in colorectal cancer treatment based on the pharmacovigilance system in China: a cohort study	14
Bioinformatics analysis identifying FBXO45 gene as a potential oncogene in esophageal cancer	14
Pancreatic cancer mortality trends in the United States: how much have we moved the needle?	14
LDHA as a predictive biomarker and its association with the infiltration of immune cells in pancreatic adenocarcinoma	14
Erratum to Construction and validation of a predictive model for the risk of three-month-postoperative malnutrition in patients with gastric cancer: a retrospective case-control study	13
Immune checkpoint inhibitors combined with paclitaxel-based chemotherapy versus chemotherapy alone as first-line treatment in HER2-negative advanced gastric cancer: result of a multicenter retrospecti	13
Effect of perioperative blood transfusion (BTF) on elderly gastric cancer patients	13
Sarcomatoid change in combined hepatocellular carcinoma and cholangiocarcinoma as a poor prognostic factor	13
Clinical outcome of non-curative endoscopic submucosal dissection for early gastric cancer	13
Determining the optimal number of examined lymph nodes for prognosis in colon cancer: a population-based study stratified by tumor location and T stage	13
Liquid-liquid phase separation-related features of PYGB/ACTR3/CCNA2/ITGB1/ATP8A1/RAP1GAP2 predict the prognosis of pancreatic cancer	13
Latin American young patients with gastric adenocarcinoma: worst prognosis and outcomes	13
LRG1 in pancreatic cancer cells promotes inflammatory factor synthesis and the angiogenesis of HUVECs by activating VEGFR signaling	12
Insights and recommendations for enhancing the prognostic nomogram in elderly patients with stage II–III colorectal cancer	12
What is the significance of mismatch repair deficiency in stage IV colon cancer?	12
A novel robust nomogram based on preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) for predicting lymph node metastasis of gastric cancer	12
Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank	12
Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocol	12
Clinical significance of transjugular intrahepatic portosystemic shunting for hepatocellular carcinoma complicated with portal hypertension	12
Identification of methyltransferase-like protein 11B as a new prognostic biomarker for colorectal cancer through an analysis of The Cancer Genome Atlas	12
Validating the PSOGI classification of peritoneal disease from non-carcinoid epithelial appendiceal neoplasms in the curative and palliative setting: an observational retrospective study	12
CBX3 is associated with metastasis and glutathione/glycosphingolipid metabolism in colon adenocarcinoma	11
KCNC3 as a prognostic indicator and a predictive marker for immunotherapy in colorectal cancer	11
Duodenal neuroendocrine tumors: how safe is endoscopic resection?	11
A comparison of two methods of lymph node dissection along the left recurrent laryngeal nerve in McKeown minimally invasive esophagectomy	11
Two autopsied gastric cancer cases of rare drug-induced pneumonia associated with nivolumab plus S-1 and oxaliplatin: a case report	11
Another hammer, but we need a wrench, and a screwdriver—positron emission tomography/magnetic resonance imaging represents another tool for post-delivery 90Y dosimetry, but what are we still missing?	11
Treatment at a high-volume academic research program mitigates racial disparities in pancreatic adenocarcinoma	11
The relationship between GLIM-malnutrition, post-operative complications and long-term prognosis in elderly patients undergoing colorectal cancer surgery	11
Evaluation of the tumoricidal efficacy of adoptive cell transfer using hepatocellular carcinoma-derived organoids	11
A bioinformatics analysis and an experimental validation of the hypoxia-related prognostic model	11
A bioinformatics analysis of potential cellular communication networks in non-alcoholic steatohepatitis and colorectal adenoma using scRNA-seq and bulk-seq	11
Identification and validation of the microRNAs and hub genes for pancreatic ductal adenocarcinoma by an integrated bioinformatic analysis	11
A narrative review of systemic treatment options for hepatocellular carcinoma: state of the art review	11
Does chemotherapy regimen matter in the neoadjuvant treatment of esophageal cancer?	11
Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer	10
Gastric and colorectal cancer incidence attributable to dietary factors in Korea	10
Liver transplantation in a patient with metastatic hepatocellular carcinoma after downstaging with single-agent immunotherapy: the first case report	10
Exosomal miR-125b-5p derived from cancer-associated fibroblasts promotes the growth, migration, and invasion of pancreatic cancer cells by decreasing adenomatous polyposis coli (APC) expression	10
A germline variant of ring finger protein 43 in an early onset, treatment-resistant metastatic gastric cancer: a case report	10
Clinical features of biliary tract cancer in Japanese individuals with Lynch syndrome	10
Effects of anlotinib combined with camrelizumab and chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma on tumor immune microenvironment	10
Risk of de novo esophageal cancer in liver transplant recipients: systematic review and meta-analysis	10
Biomarker-driven therapeutic strategies in advanced gastric cancer: a case series of curative responses	10
Sarcopenia with systemic inflammation can predict survival in patients with hepatocellular carcinoma undergoing curative resection	10
Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab	10
Radiomics based on machine learning algorithms could predict prognosis and postoperative chemotherapy benefits of patients with gastric cancer: a retrospective cohort study	10
Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?	10

The efficacy-associated biomarkers for immune checkpoint inhibitors in gastrointestinal cancer: a literature review	10
Construction and validation of a predictive model for the risk of three-month-postoperative malnutrition in patients with gastric cancer: a retrospective case-control study	10
MiR-107 inhibits the malignant biological behavior of esophageal squamous cell carcinoma by targeting TPM3	10
Circ_0000799 promotes proliferation and invasion in colorectal cancer and epithelial-mesenchymal transition	10
Prognostic evaluation of a multi-target magnetic bead-enriched circulating tumor cell-enriched identification system for colorectal cancer	9
A prognostic nomogram integrating carcinoembryonic antigen levels for predicting overall survival in elderly patients with stage II–III colorectal cancer	9
PANoptosis-associated genes exhibit significant potential in the diagnosis of hepatocellular carcinoma	9
MiR-873-5p targets THUMPD1 to inhibit gastric cancer cell behavior and chemoresistance	9
A randomized trial of negative pressure wound therapy technology combined with intermittent instillation in the treatment of neck anastomotic leakage after esophageal cancer surgery	9
Peripheral blood neutrophil-to-lymphocyte ratio as a prognostic marker and its association with the tumor-immune microenvironment in pancreatic cancer: a retrospective cohort study	9
Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study	9
Mismatch repair deficiency confers worse survival in stage IV colon cancer	9
Identification and validation of a ferroptosis-related long non-coding RNA signature as a prognostic biomarker for hepatocellular carcinoma	9
Immunotherapy in synchronous MSI-H rectal adenocarcinoma and upper tract urothelial carcinoma: a case report	9
IL-1 receptor-associated kinase 1 participates in the modulation of the NLRP3 inflammasome by tumor-associated macrophages in hepatocellular carcinoma	9
Integrating T-cell inflammation features for prognosis in hepatocellular carcinoma: a novel predictive model	9
Locally advanced anal small cell carcinoma with durable complete response to chemoradiation followed by consolidation chemotherapy: case report and literature review	9
Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin	9
Investigation of the accuracy of magnetic resonance cholangiography and multi-slice spiral computed tomography in the diagnosis of cholangiocarcinoma	9
Tripartite motif 52 (TRIM52) promotes proliferation, migration, and regulation of colon cancer cells associated with the NF-κB signaling pathway	9
Circulating tumor DNA analysis guiding adjuvant treatment in resected stage III cholangiocarcinoma: a case report	9
A novel miRNA-based model for predicting the 3-year recurrence risk of hepatocellular carcinoma following liver transplantation	9
Increasing colorectal cancer screening uptake—time to consider a more holistic socio-ecological approach	9
Compared to preoperative plasma levels post-operative urokinase-type plasminogen activator-1 levels are persistently elevated for 6 weeks after minimally invasive colorectal resection	8
The clinical effect of conversion surgery for advanced gastric cancer patients with peritoneal metastasis	8
Unexpected plasmablastic lymphoma in a young adult with unknown HIV infection: case report	8
Diagnostic value of endoscopic ultrasound versus indocyanine green fluorescence imaging for sentinel and lymph node metastasis in patients with colorectal cancer	8
Tumor mutation burden in gastro-entero-pancreatic-neuroendocrine neoplasms	8
PRRX1 promotes colorectal cancer stemness and chemoresistance via the JAK2/STAT3 axis by targeting IL-6	8
Evolving survival patterns in pancreatic adenocarcinoma: a 23-year retrospective observational analysis	8
Impact of prolonged surgical waiting time on cancer-specific mortality in stage I–II pancreatic ductal adenocarcinoma patients who received radical resection	8
Efficacy and safety of transarterial chemoembolization alone compared to its combination with anlotinib among patients with intermediate or advanced stage hepatocellular carcinoma: a phase II randomiz	8
Development and validation of a nomogram to predict cancer-specific survival of patients with large hepatocellular carcinoma accepting surgical resection: a real-world analysis based on the SEER datab	8
Utility of tumor-informed circulating tumor DNA in the clinical management of gastrointestinal malignancies	8
Study on efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with regorafenib and PD-1 antibody versus continued TACE combined with regorafenib in patients with hepatocellu	8
Time-trends in liver cancer incidence and mortality rates in the U.S. from 1975 to 2017: a study based on the Surveillance, Epidemiology, and End Results database	8
High levels of triglycerides, apolipoprotein B, and the number of colorectal polyps are risk factors for colorectal polyp recurrence after endoscopic resection: a retrospective study	8
Development and validation of a LASSO-based nomogram for predicting anastomotic leakage in elderly patients after laparoscopic gastrectomy	8
Camrelizumab in combination with chemotherapy and targeted therapy improves the prognosis in patients with advanced biliary tract cancer: a single-center retrospective clinical study	8
Andrographolide potentiates anti-tumor immunity in colorectal cancer (CRC) by targeting voltage-dependent anion channel (VDAC) and activating the cGAS-STING axis	8
Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study	8
Development and experimental validation of a senescence-related long non-coding RNA signature for prognostic prediction and immune microenvironment characterization in gastric cancer patients	8
Is the transverse colon the new right?—similarities in EGFR drug response and prognosis	8
Clinical outcomes of definitive radiotherapy for patients with cT1aN0M0 esophageal cancer unsuitable for endoscopic resection and surgery	8
Perioperative lymphocyte-to-monocyte ratio changes plus CA199 in predicting the prognosis of patients with gastric cancer	8
Comprehension of rectosigmoid junction cancer molecular features by comparison to the rectum or sigmoid colon cancer	8
Efficacy and safety of toripalimab with fruquintinib in the third-line treatment of refractory advanced metastatic colorectal cancer: results of a single-arm, single-center, prospective, phase II clin	7
The molecular sub-type and the development and validation of a prognosis prediction model based on endocytosis-related genes for hepatocellular carcinoma	7
Prognosis comparison between hepatocellular carcinoma patients with microvascular invasion who received hepatectomy alone and those who underwent early PA-TACE: a retrospective cohort study	7
Effect of urokinase-type plasminogen activator combined with clinical stage and Barcelona Clinic Liver Cancer stage on the prognosis of patients with hepatocellular carcinoma	7
The bevacizumab plus oxaliplatin-based chemotherapy regimen is more suitable for metastatic colorectal cancer patients with a history of schistosomiasis: a clinical retrospective analysis	7
Racial disparities and standard treatment in locally advanced rectal cancer: a National Cancer Database study	7
Negative hyperselection beyond RAS: is a key tool for choosing the optimal maintenance treatment in metastatic colorectal cancer?	7
Clinical characteristics, survival and prognostic nomogram for patients with esophageal mucinous adenocarcinoma: a SEER population-based analysis	7
Dynamics of neutrophil-to-lymphocyte ratio predict outcomes of metastatic colorectal carcinoma patients treated by FOLFOX	7
Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?	7
Extent of venous resection during pancreatectomy—finding the balance of technical possibility and feasibility	7
Rare germline chromosome 1 duplication identified in young male with colon cancer: a case report investigating causality	7
Radiofrequency ablation has similar short-term effects but significantly lowers the long-term effect compared with routine resection in the treatment of small hepatocellular carcinoma	7
Inflammatory pseudotumor-like extranodal classic Hodgkin lymphoma manifesting as bowel perforation in acquired immunodeficiency syndrome patient with disseminated leishmaniasis: a case report and appr	7
Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: a retrospective st	7
Changing of gamma-H2AX in peripheral blood mononuclear cells during concurrent chemoradiation in locally advanced rectal cancer patients: a potential response predictor	7
Model construction and risk analysis of the lncRNA genes associated with the prognosis of esophageal adenocarcinoma with immune infiltration	7
A retrospective study of clinicopathological characteristics and prognostic factors of Krukenberg tumor with gastric origin	7
Multi-omics analyses develop and validate the optimal prognostic model on overall survival prediction for resectable hepatocellular carcinoma	7
The clinical outcomes of patients with vascular invasion after deceased donor liver transplantation	7
Circ_0007099 upregulates GNG7 to function as a tumor inhibitor in gastric carcinoma by interacting with miR-425-3p	7
Potential molecular metabolic mechanisms underlying the effects of cimifugin in gastric cancer through single-cell and bulk RNA sequencing combined with network pharmacology	7
Clinical outcomes of first line FOLFIRINOX vs. gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer at the Yale Smilow Hospital System	7
Development and validation of machine learning models for postoperative venous thromboembolism prediction in colorectal cancer inpatients: a retrospective study	7
Role of chemoradiation in gallbladder cancer—a single institution retrospective analysis	7
Conversion surgery by hand-assisted laparoscopic surgery following chemotherapy for rectal cancer with H3 liver metastases: a case report	7
Integrated omics analysis: the relationship between significantly increased Klebsiella post-hepatectomy and decreased hub-metabolite 3-methyl-2-oxobutanoic acid is associated with induced liver failur	7
NOVA2 regulates the properties of liver cancer stem cells and lenvatinib resistance in hepatocellular carcinoma via the Wnt pathway	7
Addition of transarterial chemoembolization improves outcome of tyrosine kinase and immune checkpoint inhibitors regime in patients with unresectable hepatocellular carcinoma	7
Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literature	6
Circular RNA ZFR promotes cell cycle arrest and apoptosis of colorectal cancer cells via the miR-147a/CACUL1 axis	6
Cadherin dysregulation in gastric cancer: insights into gene expression, pathways, and prognosis	6
Erratum to Colon cancer-associated transcript-1 enhances glucose metabolism and colon cancer cell activity in a high-glucose environment in vitro and in vivo	6
Patterns of regional lymph node metastasis predict postoperative overall survival and disease-free survival in locally advanced esophageal squamous cell carcinoma	6

The emerging role of intra-tumoral bacteria	6
Parkinson’s disease and the risk of gastrointestinal cancers: a two-sample Mendelian randomization study	6
Rectal gastrointestinal stromal tumor with metachronous liver metastasis demonstrated no relapse after multidisciplinary team discussion and comprehensive treatment: a case report	6
PD-1 inhibition combined with intensity-modulated radiotherapy, to better serve patients with retroperitoneal lymph node metastases from gastrointestinal cancer	6
Artemisinin inhibits the development of esophageal cancer by targeting HIF-1α to reduce glycolysis levels	6
Screening of a novel autophagy-related prognostic signature and therapeutic targets in hepatocellular carcinoma	6
Chemoprotective effect of boeravinone B against 1,2-dimethyl hydrazine induced colorectal cancer in rats via suppression of oxidative stress and inflammatory reaction	6
Patterns-of-care disparities among uninsured versus insured patients with anorectal carcinoma referred for radiotherapy at an Urban Safety-Net Hospital	6
Current management of gastric adenocarcinoma: a narrative review	6
A prognostic nomogram based on desmoplastic reaction/tumor deposit modified lymph node staging in colorectal cancer	6
Hepatoid adenocarcinoma of the stomach: discrimination from conventional gastric adenocarcinoma with a computed tomography-based radiomics nomogram	6
Function of hsa_circ_0006646 as a competing endogenous RNA to promote progression in gastric cancer by regulating the miR-665–HMGB1 axis	6
Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis	6
Identification of prognostic biomarkers in colorectal cancer through multi-omics profiling of programmed cell death pathways	6
Effect of ramucirumab plus paclitaxel in advanced gastric cancer according to the status of programmed cell death-ligand 1 (PD-L1) expression	6
Primary gastric squamous cell carcinoma in a young adult with immunotherapy complications: a case report	6
Interleukin 13 participates in terminal differentiation of esophageal squamous cell carcinoma cells	6
Molecular subtyping and IMScore based on immune-related pathways, oncogenic pathways, and DNA damage repair pathways for guiding immunotherapy in hepatocellular carcinoma patients	6
Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study	6
Correlation analysis of intestinal flora and immune function in patients with primary hepatocellular carcinoma	6
Clinical application of nano-carbon to improve the accuracy of lymph node staging in patients with advanced gastric cancer receiving neoadjuvant chemotherapy: a prospective randomized controlled trial	6
Impact of occlusal support on postoperative complications in patients with colorectal cancer resections	6
ACTR3 promotes cell migration and invasion by inducing epithelial mesenchymal transition in pancreatic ductal adenocarcinoma	6
Efficacy and safety of dose adjustment for fruquintinib in the third-line treatment of metastatic colorectal cancer: a retrospective study with real-world settings	6
Survival outcome and prognostic factors of remnant gastric cancer: a propensity score-matched analysis	6
RNA-binding protein ENO1 promotes the tumor progression of gastric cancer by binding to and regulating gastric cancer-related genes	6
Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma	6
ZNF326 as a potential prognostic and predictive biomarker in stage II colorectal cancer	6
Nomogram-based prognostic stratification for patients with large hepatocellular carcinoma: a population study of SEER database and a Chinese cohort	6
Efficacy and safety of arterial FOLFOX chemotherapy plus anti-PD-(L)1 immunotherapy as a first-line treatment for unresectable intrahepatic cholangiocarcinoma: a propensity score matching analysis	6
Luteolin suppresses the growth of colon cancer cells by inhibiting the IL-6/STAT3 signaling pathway	6
Development and validation of a dual-energy CT-based model to estimate the malignant probability of distal gastric wall thickening	6
Erratum: Activation of RhoA/ROCK2 signaling by hypoxia-inducible factor 1α in promoting tumor growth and metastasis in human colon cancer	6
Effects of recombinant human adenovirus type 5 combined with transarterial chemoembolization on postoperative metastasis and recurrence of hepatocellular carcinoma patients	6
Six mutator-derived lncRNA signature of genome instability for predicting the clinical outcome of colon cancer	6
Efficacy and safety of transarterial chemoembolization-lenvatinib sequential therapy for the treatment of hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study	5
Identification of a potential competing endogenous RNA (ceRNA) network in gastric adenocarcinoma	5
The role of TMSB15A in gastric cancer progression and its prognostic significance	5
Multiple primary tumors in patients with surgically treated pancreatic cancer: a SEER population-based study	5
A retrospective cohort study on the efficacy and safety for combination therapy of immunotherapy, targeted agent, and chemotherapy versus immunochemotherapy or chemotherapy alone in the first-line tre	5
Outcomes of patients with metastatic pancreatic cancer who progress on first restaging imaging	5
Balancing anticancer therapy efficacy and safety in advanced hepatocellular carcinoma: a case report	5
Systematic review and meta-analysis of the prognostic role of fibroblast-activation protein in gastrointestinal cancers	5
A machine learning clinic scoring system for hepatocellular carcinoma based on the Surveillance, Epidemiology, and End Results database	5
A randomized controlled trial of positive end-expiratory pressure on pulmonary oxygenation and biventricular function in esophageal cancer patients receiving one-lung ventilation under a lower FiO2	5
Identification of 8-gene risk prediction signature associated with NOTCH1 in stomach adenocarcinoma based on bioinformatics analysis	5
A case series of 10 patients undergone linear cutter/stapler guiding device-led overlapped esophagojejunostomy: a preliminary study	5
A microarray expression profile and bioinformatic analysis of circular RNA in human esophageal carcinoma	5
Resectable, borderline, and locally advanced pancreatic cancer—“the good, the bad, and the ugly” candidates for surgery?	5
SPP1 promotes tumor progression in esophageal carcinoma by activating focal adhesion pathway	5
Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study	5
Comparison of efficacy and safety between pembrolizumab combined with chemotherapy and simple chemotherapy in neoadjuvant therapy for esophageal squamous cell carcinoma	5
Characterization of somatic mutations and pathway alterations during hepatocellular carcinoma vascular invasion using next-generation sequencing	5
Prediction and validation of circulating G-quadruplexes as a novel biomarker in colorectal cancer	5
Magnetic resonance imaging-based radiomics in predicting the expression of Ki-67, p53, and epidermal growth factor receptor in rectal cancer	5
Lymph node metastasis-related lncRNA GAS6-AS1 facilitates the progression of esophageal squamous cell carcinoma	5
Selecting surgical candidates with locally advanced pancreatic cancer: a review for modern pancreatology	5
Conversion resection of initially unresectable hepatocellular carcinoma associated with steatohepatitis through hepatic artery infusion chemotherapy-transarterial chemoembolization and systemic therap	5
Combined screening analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma	5
Combined detection of preoperative neutrophil to lymphocyte ratio and interleukin-6 as an independent prognostic factor for patients with non-metastatic colorectal cancer	5
Clinical and molecular characteristics of periampullary carcinoma based on pathological subtypes	5
Bioinformatics analysis of immune infiltrates and tripartite motif (TRIM) family genes in hepatocellular carcinoma	5
Surgical microwave ablation for multifocal non-resectable liver metastases: a single institution experience treating five or more liver lesions	5
Knockdown of Obg-like ATPase 1 enhances sorafenib sensitivity by inhibition of GSK-3β/β-catenin signaling in hepatocellular carcinoma cells	5
Inflammatory bowel disease-associated malignancies and considerations for radiation impacting bowel: a scoping review	5
The surgical perspective on CAIRO5 and beyond: all patients with colorectal liver metastases should be evaluated by a liver surgeon, but what defines resectability?	5
A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data	5
Safety and short-term outcomes of esophagectomy after neoadjuvant immunotherapy combined with chemotherapy or chemoradiotherapy for locally advanced esophageal squamous cell cancer: analysis of two ph	5
Drug-eluting bead transarterial chemoembolization could improve the hepatic hemodynamics of patients with unresectable hepatocellular carcinoma: a retrospective cohort study	5
Prognostic and immune infiltrates for the Chromobox (CBX) protein family in human pancreatic adenocarcinoma	5
Transcatheter arterial chemoembolization with tyrosine kinase inhibitor in the 12-year treatment of hepatic metastases from gastrointestinal stromal tumor: a case report	5
Is radix ligation of the inferior mesenteric artery effective in Japanese-Style D3 radical lymph node dissection for sigmoid colon and rectal cancer surgery?—a single-center retrospective analysis sin	5
Camrelizumab plus sorafenib or apatinib achieved long-term survival in a patient with hepatocellular carcinoma and an Eastern Cooperative Oncology Group performance status of 3: a case report	5
Identification of potential prognostic biomarkers among gene models for coiled-coil domain-containing family members in hepatocellular carcinoma elucidates their influence on the hypoxia pathway and i	5
BCLC stage C hepatocellular carcinoma: modern therapeutic strategies in the age of immunotherapy	5
Prognostic prediction and gene regulation network of EIF2S2 in hepatocellular carcinoma based on data mining	5
Regorafenib combined with immune checkpoint inhibitors versus regorafenib monotherapy as a late-line treatment for metastatic colorectal cancer: a single-center, retrospective cohort study	5
A narrative review of the evolving role of immunotherapy in the management of esophageal and gastric cancer	5
Development and validation of a nomogram based on neutrophil-to-lymphocyte ratio and fibrinogen-to-lymphocyte ratio for predicting recurrence of colorectal adenoma	5
Nutritional index for immune-checkpoint inhibitor in patients with metastatic gastro-esophageal junction/gastric cancer	5
Construction and validation of a novel prognostic model using the cellular senescence-associated long non-coding RNA in gastric cancer: a biological analysis	5
Construction of a competing endogenous RNA network related to the prognosis of cholangiocarcinoma and comprehensive analysis of the immunological correlation	5
Prospective comparison of positron emission tomography (PET)/magnetic resonance and PET/computed tomography dosimetry in hepatic malignant neoplastic disease after 90Y radioembolization treatment	5
The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancer	5
Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy	5
Global burden of gastric cancer attributed to high-salt diets: spatiotemporal trends and socio-demographic inequalities from 1990 to 2021	5
The expression and clinical value of tumor infiltrating dendritic cells in tumor tissues of patients with esophageal cancer	5
Identification and validation of ferroptosis-associated gene-based on immune score as prognosis markers for hepatocellular carcinoma patients	5
Outcomes in octogenarians following elective colorectal cancer surgery	5
Analysis of the efficacy and safety of paclitaxel (albumin-bound) combined with S-1 and oxaliplatin combined with S-1 in the first-line treatment of advanced gastric cancer: a cohort study	5
Using an indocyanine green fluorescent imaging technique for laparoscopic rectal cancer surgery: a case report	5
Machine learning-based analysis identifies a 13-gene prognostic signature to improve the clinical outcomes of colorectal cancer	5
Advanced approaches to loco-regional and surgical management for hepatocellular carcinoma	4
Cultural and social barriers to hope in gastrointestinal cancer patients	4
Treatment heterogeneity and overall survival in patients with advanced/metastatic gastric or gastroesophageal junction adenocarcinoma in the United States	4